Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
To understand the dose-response characteristics of PF-00885706 for efficacy in terms of
symptomatic relief when used as add-on treatment to esomeprazole 20mg (standard proton pump
inhibitor [PPI] treatment), in subjects with gastro-esophageal reflux (GERD) who have
inadequate relief with PPIs.